Evidence map›Paper›PMID 37947183›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2024

Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

Lauren Jeffries, Emily K Mis, Kirsty McWalter, Sandra Donkervoort, Nina N Brodsky, Jean-Marie Carpier, Weizhen Ji, Cristian Ionita, Bhaskar Roy, Jon S Morrow and 42 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Genes · 2025
    Article
  4. BiallelicBrain communications · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

52 authors at 20 institutions in 3 countries.

Lauren JeffriesYale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT.
Emily K MisYale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT.
Kirsty McWalterGeneDx, Gaithersburg, MD.
Sandra DonkervoortNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
Nina N BrodskyYale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT; Yale University School of Medicine, Department of Immunobiology, New Haven, CT.
Jean-Marie CarpierYale University School of Medicine, Department of Immunobiology, New Haven, CT.
Weizhen JiYale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT.
Cristian IonitaYale University School of Medicine, Department of Pediatrics, New Haven, CT.
Bhaskar RoyYale University School of Medicine, Department of Neurology, New Haven, CT.
Jon S MorrowYale University School of Medicine, Department of Pathology, New Haven, CT.
Armine DarbinyanYale University School of Medicine, Department of Pathology, New Haven, CT.
Krishna IyerYale University School of Medicine, Department of Pathology, New Haven, CT.
Ritu B AulHospital for Sick Children, Division of Clinical and Metabolic Genetics, Toronto, Ontario, Canada.
Siddharth BankaManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, United Kingdom; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Katherine R ChaoCenter for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA.
Laura CobboldSouth West Thames Regional Genetics Service, St George's, University of London, London, United Kingdom.
Stacey CohenChildren's Hospital of Philadelphia, Division of Neurology, Philadelphia, PA; The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of Philadelphia, Philadelphia, PA; University of Pennsylvania Perelman School of Medicine, Department of Neurology, Philadelphia, PA.
Helena M CustodioDepartment of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom; Chalfont Centre for Epilepsy, Buckinghamshire, United Kingdom.
Margaret Drummond-BorgCook Children's Medical Center, Division of Genetics, Fort Worth, TX.
Frances ElmslieSouth West Thames Regional Genetics Service, St George's, University of London, London, United Kingdom.
Erika FinangerOregon Health & Science University, Portland, OR.
Bryan E HainlineIndiana University School of Medicine, Indiana University Health Physicians, Indianapolis, IN.
Ingo HelbigChildren's Hospital of Philadelphia, Division of Neurology, Philadelphia, PA; University of Pennsylvania Perelman School of Medicine, Department of Neurology, Philadelphia, PA.
Stacy HewsonHospital for Sick Children, Division of Clinical and Metabolic Genetics, Toronto, Ontario, Canada.
Ying HuNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
Adam JacksonManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, United Kingdom; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Dragana JosifovaGuys and St Thomas NHS Trust, Clinical Genetics, London, United Kingdom.
Monica KonstantinoYale Pediatric Genomics Discovery Program, New Haven, CT.
Meganne E LeachOregon Health & Science University, Portland, OR.
Bryan MakUniversity of California Los Angeles, David Geffen School of Medicine, Department of Human Genetics, Los Angeles, CA; Current affiliation: Genome Medical, South San Francisco, CA.
David McCormickKing's College Hospital, Paediatric Neurosciences, London, United Kingdom.
Elisabeth McGeeUniversity of California Los Angeles, David Geffen School of Medicine, Department of Human Genetics, Los Angeles, CA; University of California Los Angeles, Clinical Genomics Center, Los Angeles, CA; University of California Los Angeles, Center for Duchenne Muscular Dystrophy, Los Angeles, CA.
Stanley NelsonUniversity of California Los Angeles, David Geffen School of Medicine, Department of Human Genetics, Los Angeles, CA; University of California Los Angeles, Clinical Genomics Center, Los Angeles, CA; University of California Los Angeles, Center for Duchenne Muscular Dystrophy, Los Angeles, CA.
Joanne NguyenCook Children's Medical Center, Division of Genetics, Fort Worth, TX.
Kimberly NugentBaylor College of Medicine, Department of Pediatrics, Houston, TX; Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX; Current affiliation: Cooper Surgical, Trumbull, CT.
Lucy OrtegaCook Children's Medical Center, Division of Genetics, Fort Worth, TX.
Howard P GoodkinUniversity of Virginia School of Medicine, Charlottesville, VA.
Elizabeth RoederBaylor College of Medicine, Department of Pediatrics, Houston, TX; Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX.
Sani RoyCook Children's Medical Center, Division of Endocrinology and Diabetes, Fort Worth, TX.
Katie SappIndiana University School of Medicine, Indiana University Health Physicians, Indianapolis, IN.
Dimah SaadeNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Current affiliation: University of Iowa Carver College of Medicine, Iowa City, IA.
Sanjay M SisodiyaDepartment of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom; Chalfont Centre for Epilepsy, Buckinghamshire, United Kingdom.
Karen StalsRoyal Devon & Exeter NHS Foundation Trust, Exeter Genomics Laboratory, Exeter, United Kingdom.
Shelley TownerUniversity of Virginia School of Medicine, Charlottesville, VA.
William WilsonUniversity of Virginia School of Medicine, Charlottesville, VA.
Deciphering Developmental Disorders
Genomics England Research Consortium
Undiagnosed Disease Network
Mustafa K KhokhaYale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT; Yale University School of Medicine, Department of Genetics, New Haven, CT.
Carsten G BönnemannNeuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
Carrie L LucasYale Pediatric Genomics Discovery Program, New Haven, CT; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
Saquib A LakhaniYale University School of Medicine, Department of Pediatrics, New Haven, CT; Yale Pediatric Genomics Discovery Program, New Haven, CT. Electronic address: saquib.lakhani@yale.edu.
Yale University · USNational Institutes of Health · USCook Children's Medical Center · USSt George's, University of London · GBUniversity of California, Los Angeles · USUniversity of Manchester · GBBaylor College of Medicine · USKing's College Hospital · GBUniversity of Virginia · USIndiana University Health · USChildren's Hospital of Philadelphia · USNational Hospital for Neurology and Neurosurgery · GBBroad Institute · USOregon Health & Science University · USRoyal Devon & Exeter NHS Foundation Trust · GBEpilepsy Research UK · GBHospital for Sick Children · CASt Mary's Hospital · GBGuy's and St Thomas' NHS Foundation Trust · GBID Genomics (United States) · US

Funding

Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
Molecular and Clinical Manifestations of Matrix and Aggregate MyopathiesZIANS003129 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI BÖNNEMANN, CARSTEN · 2011 to 2025
$52.8M
Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
Project 3 - Development and investigation of murine models of channelopathy-associated epilepsyU54NS108874 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KISKINIS, EVANGELOS · 2018 to 2022
$12.1M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI SCHULTZ, ROBERT THOMAS · 2016 to 2020
$6.3M
A system approach to the analysis of Heterotaxy Candidate GenesR01HD102186 · NICHD · YALE UNIVERSITY · PI KHOKHA, MUSTAFA K · 2020 to 2024
$3.1M
A powerful web-based discovery platform for rare disease geneticsR01HG009141 · NHGRI · BROAD INSTITUTE, INC. · PI QUINLAN, AARON R, REHM, HEIDI L · 2017 to 2020
$2.9M
A computational phenotyping approach to characterize neurogenetic disordersR01NS131512 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Ingo Helbig · 2023 to 2026
$2.8M
Genetics of Epilepsy in Mali (GENEP-Mali)R01NS118522 · NINDS · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI LAKHANI, SAQUIB A, LANDOURE, GUIDA · 2021 to 2025
$2.4M
ClinGen Expert Curation Panel for the EpilepsiesU24NS120854 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Ingo Helbig, HEATHER C. MEFFORD · 2021 to 2026
$2.0M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
Joint analysis of genomic and electronic medical record data to assess outcomes and drug response in pediatric epilepsiesK02NS112600 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI HELBIG, INGO · 2020 to 2024
$963k
Intramural NIH HHSMedical Research Council MC_EX_MR/M009203/1Medical Research Council MC_PC_14089Medical Research Council MR/M009203/1NCATS NIH HHS UL1 TR001878NHGRI NIH HHS R01 HG009141NHGRI NIH HHS UM1 HG008900NICHD NIH HHS R01 HD102186NICHD NIH HHS U54 HD086984NIH HHS S10 OD030363NINDS NIH HHS K02 NS112600NINDS NIH HHS R01 NS118522NINDS NIH HHS R01 NS131512NINDS NIH HHS U01 NS134356NINDS NIH HHS U24 NS120854NINDS NIH HHS U54 NS108874Wellcome Trust
6 · The paper itself

Abstract

purposeWe sought to delineate a multisystem disorder caused by recessive cysteine-rich with epidermal growth factor-like domains 1 (CRELD1) gene variants.

methodsThe impact of CRELD1 variants was characterized through an international collaboration utilizing next-generation DNA sequencing, gene knockdown, and protein overexpression in Xenopus tropicalis, and in vitro analysis of patient immune cells.

resultsBiallelic variants in CRELD1 were found in 18 participants from 14 families. Affected individuals displayed an array of phenotypes involving developmental delay, early-onset epilepsy, and hypotonia, with about half demonstrating cardiac arrhythmias and some experiencing recurrent infections. Most harbored a frameshift in trans with a missense allele, with 1 recurrent variant, p.(Cys192Tyr), identified in 10 families. X tropicalis tadpoles with creld1 knockdown displayed developmental defects along with increased susceptibility to induced seizures compared with controls. Additionally, human CRELD1 harboring missense variants from affected individuals had reduced protein function, indicated by a diminished ability to induce craniofacial defects when overexpressed in X tropicalis. Finally, baseline analyses of peripheral blood mononuclear cells showed similar proportions of immune cell subtypes in patients compared with healthy donors.

conclusionThis patient cohort, combined with experimental data, provide evidence of a multisystem clinical syndrome mediated by recessive variants in CRELD1.

Indexed as

Neurodevelopmental DisordersReinfectionArrhythmias, CardiacCell Adhesion MoleculesExtracellular Matrix ProteinsHumansLeukocytes, MononuclearPhenotypeSyndromeCell Adhesion MoleculesCRELD1 protein, humanExtracellular Matrix ProteinsCardiac arrythmiaCRELD1Developmental delayEpilepsyHypotonia

Identifiers

PMID37947183
PMCPMC10932913
OpenAlexW4388461661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.